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Abstract
Background: Measurement of malaria endemicity is typically based on vector or
parasite measures. A complementary approach is the detection of parasite specific
IgG antibodies. We determined the antibody levels and seroconversion rates to
both P. vivax and P. falciparum merozoite antigens in individuals living in areas of
varying P. vivax endemicity in Para´ state, Brazilian Amazon region.
Methodology/Principal Findings: The prevalence of antibodies to recombinant
antigens from P. vivax and P. falciparum was determined in 1,330 individuals. Cross
sectional surveys were conducted in the north of Brazil in Anaja´s, Bele´m, Goiane´sia
do Para´, Jacareacanga, Itaituba, Traira˜o, all in the Para´ state, and Sucuriju, a free-
malaria site in the neighboring state Amapa´. Seroprevalence to any P. vivax
antigens (MSP1 or AMA-1) was 52.5%, whereas 24.7% of the individuals were
seropositive to any P. falciparum antigens (MSP1 or AMA-1). For P. vivax antigens,
the seroconversion rates (SCR) ranged from 0.005 (Sucuriju) to 0.201 (Goiane´sia
do Para´), and are strongly correlated to the corresponding Annual Parasite Index
(API). We detected two sites with distinct characteristics: Goiane´sia do Para´ where
seroprevalence curve does not change with age, and Sucuriju where
seroprevalence curve is better described by a model with two SCRs compatible
with a decrease in force of infection occurred 14 years ago (from 0.069 to 0.005).
For P. falciparum antigens, current SCR estimates varied from 0.002 (Bele´m) to
0.018 (Goiane´sia do Para´). We also detected a putative decrease in disease
transmission occurred ,29 years ago in Anaja´s, Goiane´sia do Para´, Itaituba,
Jacareacanga, and Traira˜o.
Conclusions:We observed heterogeneity of serological indices across study sites
with different endemicity levels and temporal changes in the force of infection in
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some of the sites. Our study provides further evidence that serology can be used to
measure and monitor transmission of both major species of malaria parasite.
Introduction
Efforts in mapping malaria transmission have demonstrated a wider geographical
distribution of the parasite Plasmodium vivax compared to P. falciparum [1, 2].
The number of clinical cases due to P. vivax infection has been estimated from 106
to 313 million cases per year across the world [3]. In South America, P. vivax is
currently the most predominant malaria species [2–5] and the Brazilian Amazon
region has been considered a natural frontier for malaria transmission since 1970
[6, 7], when intense human migration led to a significant increase in the number
of malaria cases [8, 9]. In the last two decades, there were reported between
300,000 to 600,000 malaria cases per year in Brazil with P. vivax representing 75–
80% of these [7].
The control programs have had a significant impact on P. falciparum malaria
burden in Brazil, which predominated in the past [7–9], but only a moderate
effect on P. vivax infections. The high frequency of asymptomatic P. vivax carriers
in the Brazilian endemic area [10–13] together with a long period of incubation of
hypnozoites [14] might be possible explanations for this partial success in
controlling this Plasmodium species. In this setting of high proportion of
asymptomatic carriers, it is critical to have in hand good epidemiological tools in
order to assess not only the status quo of disease dynamics, but also to monitor
any change in disease transmission due to malaria control interventions.
In Brazil, variations or changes in malaria transmission have been previously
associated with intensive use of land and environmental transformations due to
farming, deforestation, or gold mining [9, 15–17]. Additionally, it has been shown
that the proportion of asymptomatic infections in native Amazonian population
tends to increase with age [12, 13]. This observation suggests that continuous
parasite exposure, even at a low rate, is enough to induce some degree of
protective immunity. The combination of these factors implies additional
difficulties in assessing the underlying malaria epidemiology of these low
transmission and ecologically variable settings.
A large sero-epidemiological study, conducted at the end of the 1960’s showed
an association between malaria endemicity and the prevalence of antibodies
against Plasmodium antigens across different South and Central American
countries [18]. Later studies using crude or recombinant antigens from P.
falciparum and/or P. vivax have confirmed these findings in Africa [19–21], Asia
[22, 23] and South America, including Brazil [12, 24–30].
Estimation of malaria transmission is routinely based on vector and parasite
measures. The possibility of relapses in P. vivax infected individuals complicates
control significantly and makes statistical inferences over parasite prevalence
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measures more problematic [2, 31]. Alternatively, serological markers are useful in
areas of low endemicity, where it is likely to be easier to detect relatively long-
lasting antibody responses than a low prevalence of symptomatic or asymptomatic
infections in the host or the entomologic infection rate [19, 32–34]. This approach
has been applied to the estimation of P. falciparum malaria transmission.
However, there is a scarce number of studies aiming to test whether
seroprevalence for P. vivax antigens can be an equally good epidemiological tool
to measure and monitor changes in malaria transmission rates. With this goal, we
have conducted a cross sectional study where we determined the antibody
prevalence to P. vivax and P. falciparum for individuals living in areas with
varying malaria endemicity levels in Para´ state, Brazilian Amazon region.
Methods
Study area
The present study was conducted in six municipalities in Para´ state in the
northern region of the country (Figure 1). Geographically, Para´ state is one among
eight states that constitute the Brazilian Amazon region and, as such, consists of
tropical forest with many rivers. This is an area of intense seasonal rainfall with
maximum levels between November and April. Malaria endemicity is typically
classified as low endemicity and occurs during and immediately after the rainy
season with the peak parasite prevalence typically registered between June and
November. The municipalities in this study were selected based on the risk of
malaria as estimated by the Brazilian office for malaria surveillance and control
[35].
The samples were collected in ten localities within the municipalities considered
to be representative of each area. The number varied from one to three localities
per municipality. These municipalities and the corresponding localities were:
Anaja´s city (central urban area); Jacareacanga (Porto Rico and Sa˜o Jose´);
Goiane´sia do Para´ (Rouxinol, Santa Paula and Ararandeua); Itaituba (Sa˜o Luiz do
Tapajo´s); Traira˜o (Treˆs Boeiras); and Bele´m city (Cotijuba island). A malaria-free
area, Sucuriju village in Amapa´ state, was also included in the study. The sampling
coverage in relation to total residents of each study site was the following: Anaja´s
(12.0%), Bele´m (15.4%), Jacareacanga (19.3%), Goiane´sia do Para´ (29.3%),
Itaituba (48.0%), Sucuriju (61.0%), and Traira˜o (81.0%). See Table 1 for further
details.
Ethics statement
This study was carried out in full accordance with all International and Brazilian
accepted guidelines as written informed consent was obtained from all
participants. The Ethics committee reviewed and approved all the consent
procedures. A signed consent form was approved for all adults and provided by
parents or guardians for children under 15 years old. For individuals between 16
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and 18 years old, the consent procedure was similar to adult participants. This
study was approved by the Federal University of Para´ (3686/2005) and by the
Evandro Chagas Institute (0014/2007 and 0031/2010) Ethics committee.
Samples and data collection
One cross-sectional survey was performed in each study site between 2006 and
2010. The total sample size was 1,330 individuals and ranged from 113 (Anaja´s) to
262 (Goiane´sia do Para´) with an average sample size of 190 individuals per
municipality. According to the malaria surveillance office of the Brazilian Ministry
of Health (SIVEP-Malaria, http://portalweb04.saude.gov.br/sivep_malaria) [35],
there are 2 areas (Bele´m and Sucuriju village) with low Annual Parasite Index
(API, number of malaria cases per year/thousand inhabitants) and other 5
(Anaja´s, Jacareacanga, Goiane´sia do Para´, Itaituba, and Traira˜o) with high API at
the time of survey (Table 1). Each survey was carried out at meeting points well
known by the respective community, such as a health office, a school or a
Figure 1. Map of the study area: A. South America, B. Brazil with Para´ state in the Amazon region, C. The sampled six municipalities.
doi:10.1371/journal.pone.0113357.g001
Table 1. Baseline characteristics of the study area where all municipalities are in the Para´ state with the exception of Sucuriju village (in the Amapa´ state).
Municipality Year of survey APIa N Age in years, median (range) Males, % Previous exposure, %
Anaja´s 2009 953.7 (high) 113 29 (2–98) 58.4 89.7
Jacareacanga 2009 138.3 (high) 172 38 (0–75) 43.0 92.4
Goiane´sia do Para´ 2010 198.7 (high) 262 34 (3–71) 45.0 88.1
Itaituba 2007 74.0 (high) 183 23 (1–81) 61.2 44.2
Traira˜o 2006 54.0 (high) 204 26 (1–82) 54.9 75.7
Sucuriju 2007 4.3 (low) 253 19 (2–83) 50.6 5.0
Bele´m 2007 0.5 (low) 143 24 (1–80) 49.7 26.6
aAnnual Parasite Index at the year of survey with the respective classification (low or high) as reported by the Brazilian Ministry of Health (www.saude.gov.br/
sivep_malaria).
Sucuriju village is usually considered as malaria-free area.
doi:10.1371/journal.pone.0113357.t001
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residential house conveniently adapted for medical attendance. Individuals
attending these facilities for medical appointments during the survey period were
included in the sample. The survey period for each locality was one to two weeks,
except in the case of Cotijuba island (Bele´m), where the sampling were carried out
for three months, one survey per week in each month. The samples were collected
in the following municipality time periods: Anaja´s - August 2009, Jacareacanga
- February 2009, Goiane´sia do Para´ - November 2010, Itaituba - March 2007,
Traira˜o - October 2006, Bele´m - between September and November 2007,
Sucuriju village in Amapa´ state - June 2007. For each participant, baseline
characteristics were recorded and comprised information on time living in the
sampling area and self-reported history of malaria including the number of
previous malaria episodes and corresponding symptoms, and, in the case of
having reported malaria during the previous year before survey, whether that was
confirmed by thick blood smear.
Blood samples were taken by finger prick to prepare thick blood smears and
collected into microtainer tubes. The tubes were centrifuged at 2000 rpm with the
sera subsequently stored at 4 C˚. The thick blood smear was examined immediately
after and parasitaemia assessed by two experienced microscopists where 200 fields
were read from each slide before being declared negative [36].
Serological assays
All sera were tested for IgG antibodies to recombinant blood-stage P. vivax and P.
falciparum malaria antigens: apical membrane antigen 1 (AMA1) and merozoite
surface protein 1 (MSP1) using quantitative enzyme-linked immunosorbent assay
(ELISA) as described elsewhere [19, 37, 38]. For P.vivax two recombinant proteins
of MSP1 (Bele´m genotype), both contained the 19 KDa C-terminal portion of
MSP1 (MSP119) in fusion with histydine tag (His6) or Glutationa S-transferase
(GST) [37], as well as AMA1 (Salvador genotype) were used. For P. falciparum
malaria antigens AMA1 (3D7) and MSP119 (Wellcome) [38]. Briefly,
Immunolon-4HBX plates were coated overnight at 4 C˚ at a concentration of
0.5 mg/ml of each recombinant antigen diluted in 50 ml per well. Plates were
washed using PBS, 0.05% Tween 20 (PBS/T) and blocked using 1% (w/v)
skimmed milk powder in PBS/T. After this step, 50 ml of each sample, a positive
control (a pool of hyperimmune serum collected from two malaria endemic area,
Gambia and Brazil in case of test with antigen from P. falciparum and P. vivax,
respectively) were added in duplicate to each plate. The sera were tested at a final
dilution of 1:1000 for both P. vivax recombinant proteins, and 1:1000 and 1:2000
for P. falciparum MSP119 and AMA1, respectively. The plates were washed and
horse-radish peroxidase conjugate rabbit anti-human IgG antibody (DAKO,
Roskilde, Denmark) was added to all wells at a dilution 1:5000 in PBS/T. Antibody
responses were detected after development with o-phenylenediamine dihy-
drochloride substrate solution (OPD) for 20 minutes. Reactions were stopped
with 25 ml per well of 2M H2SO4. Plates were read immediately at 492 nm on a
Malaria Endemicity in Brazil and Antibodies
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Molecular Devices Versa Max ELISA reader and optical density (OD) values
recorded.
Statistical analysis
Duplicate ELISA OD values were averaged and normalized against the positive
control sample on each plate. OD data was then converted to antibody titers,
expressed in Arbitrary Units (AU/ml), using a standard curve obtained from an
appropriate hyperendemic sera control. Antibody titers were calculated using the
formula: titer 5 dilution/[maximum OD/(OD test serum – minimum OD) -1]
(33). Seropositivity was determined by fitting a mixture model to normalised OD
values. The model assumed two Gaussian distributions, one for sero-negative
individuals and another for sero-positive individuals [39]. The mean OD plus
three standard deviations associated with the sero-negative group was used as the
cut-off value for seropositivity. A separate cut-off was generated for each antigen
of each species.
Seroprevalence was stratified into yearly age groups and then analyzed using a
reverse catalytic modeling approach under a binomial sampling assumption, as
described elsewhere [19, 21, 38, 39]. In this context we aimed to estimate two key
parameters (i) the seroconversion rate (SCR or l) that is the annual rate at which
individuals change from seronegative to seropositive and is related to disease
transmission intensity [19, 21, 38] and (ii) seroreversion rate (SRR or r) that is the
annual rate at which seropositive subjects revert to a seronegative state. Each data
set was analyzed using two reversible catalytic models, one that assumes a
constant-SCR over time and another that assumes a change in SCR at a given time
point. The models were estimated by means of maximum likelihood method. In
the case of the model assuming a change in SCR, we applied the profile likelihood
method to obtain the most likely time point where that change occurred [19, 21].
Where indicated, comparison between these different models was carried out by
means of likelihood ratio tests. To obtain confidence intervals and standard errors
for SCR and SRR we used bootstrap as follows: (1) re-sample with replacement
from the original data, (2) fit the best model to this new data and save the
respective estimates, (3) repeat previous steps (e.g., 1000 times) until obtaining a
sample of estimates, (4) calculate the standard deviation of the estimates sample
associated with each parameter (bootstrap-based standard error) and the 2.5%
and 97.5% quantiles (lower and upper bound of the bootstrap-based confidence
interval).
To analyze age-adjusted antibody levels, the highest titer level for antigens to
the same Plasmodium species was calculated for each individual and then log-
transformed in order to obtain Gaussian distributions approximately. The
corresponding analysis was carried out using the Michaelis-Menten model as
available in the ‘vgam’ package for the R software [40]. In the case of P. falciparum
antibody titers from Jacareacanga, we fitted two Michaelis-Menten curves using
the age cut-off obtained from the best catalytic model for the corresponding
seroprevalence curve.
Malaria Endemicity in Brazil and Antibodies
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Finally, a correlation analysis between pairs of different site-specific measures
(e.g., API versus seroconversion rates) was performed using the non-parametric
Spearman’s correlation coefficient. We also used logistic regression to correlate
previous malaria exposure with age adjusting for municipality and gender.
All statistical analysis was done in the R software (version 3.0, htpp://cran.
r-project.org) using our own scripts.
Results
Baseline data reveals regional malaria endemicity variations
The number of individuals recruited at each site ranged from 113 to 262 (Table 1).
The percentage of participants ranged from 12% (Anaja´s) to 81% (Traira˜o) of the
total residents in each locality. The percentage of individuals reporting previous
malaria infections varied widely across sites, ranging from 5% (Sucuriju) to 92.4%
(Jacareacanga) (Table 1). Although some differences across sites can be
highlighted in the age distribution and male/female proportion, data suggest two
clusters of municipalities: one comprising 5 municipalities (Anaja´s, Jacareacanga,
Goiane´sia do Para´, Itaituba and Traira˜o) with higher levels of previous exposure
and another including 2 municipalities (Bele´m and Sucuriju) where malaria
exposure is low. Previous exposure is highly and positively associated with age
(OR51.54 per 10-year increase, CI 95%5(1.40;1.68), p-value ,10215; logistic
regression adjusted for gender, age and municipality) and older individuals are
more exposed to malaria than younger ones. There was also a strong correlation
between the respective Annual Parasite Index (API) as reported by Brazilian
Ministry Health and reported malaria exposure (r50.82, Spearman’s correlation
coefficient, p50.03). Data on previous exposure to malaria would appear to
reflect the official statistics of the study area.
Seroprevalence to any P. vivax or P. falciparum antigens, or to either
Plasmodium species, also showed variation between municipalities (Table 2).
Seroprevalence for any P.vivax antigens ranged from 19.6% (Bele´m) to 77.5%
(Goiane´sia do Para´), while seroprevalence for any P. falciparum antigens is
estimated to be between 0.8% (Sucuriju) and 59.3% (Jacareacanga). As expected,
seroprevalence to any P. vivax antigens was higher than that to any P. falciparum
ones in every study site. Parasite prevalence was low and ranging from 0 to 5%.
Official API was highly correlated to the seroprevalence to any P. vivax antigen,
but only moderately correlated with that to any P. falciparum antigen (rAPI-
vivax50.86, p50.02 versus rAPI-falciparum50.64, p50.14, Spearman’s correlation
coefficient). This likely reflects the difference between the contributions of P. vivax
and P. falciparum to malaria burden, with API representing all malaria cases.
Malaria Endemicity in Brazil and Antibodies
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Seroconversion rates and antibody levels to any P. vivax antigens
and characterization of study sites by endemicity level
Seroconversion rates (SCR) were estimated in different study sites (Table 3). For
P. vivax seroprevalence, the best model for the data assumes a stable transmission
throughout time but with different transmission intensities across sites with the
exception of Sucuriju in the Amapa´ state (Figure 2A). SCR estimates for disease
transmission range from 0.005 (Sucuriju) to 0.201 (Goiane´sia do Para´), and are
strongly correlated to the corresponding yearly API (rSCR-API50.89, Spearman’s
Table 2. Parasite prevalence using thick blood smear and seroprevalence to any P. vivax and P. falciparum antigens and to any species.
Municipalitya Parasite prevalence, % Seroprevalence, % (95% confidence interval)
P. vivax P. falciparum Any species
Anaja´s 1.8 (0.2–6.2) 68.1 (58.7–76.6) 21.2 (14.1–29.9) 73.5 (64.3–81.3)
Jacareacanga 2.3 (0.6–5.8) 69.2 (61.7–76.0) 59.3 (51.6–66.7) 82.0 (75.4–87.4)
Goiane´sia do Para´ 5.0 (2.7–8.3) 77.5 (71.9–82.4) 45.8 (39.7–52.0) 87.8 (83.2–91.5)
Itaituba 0.0 (0.0–2.0) 37.7 (30.7–45.2) 12.0 (7.7–17.6) 41.5 (34.3–49.0)
Traira˜o 1.5 (0.3–4.2) 64.2 (57.2–70.8) 27.0 (21.0–33.6) 68.6 (61.8–74.9)
Sucuriju 0.0 (0.0–1.4) 28.1 (22.6–34.0) 0.8 (0.1–2.8) 28.9 (23.4–34.9)
Bele´m 0.0 (0.0–2.5) 19.6 (13.4–27.0) 2.8 (0.8–7.0) 21.0 (14.6–28.6)
All samples 1.7 (1.0–2.5) 52.5 (49.8–55.2) 24.7 (22.4–27.1) 58.1 (55.4–60.8)
aMunicipalities sorted by API at the year of the survey as shown in Table 1.
doi:10.1371/journal.pone.0113357.t002
Table 3. Statistical analysis of age-adjusted seroprevalence data using reversible catalytic models.
Seroprevalence Municipality lcurrent (95% CI) lpast (95% CI)
Any P. vivax Anaja´s 0.146 (0.096,0.236) -
Jacareacanga 0.145 (0.096,0.234) -
Goiane´sia do Para´ 0.201 (0.125,0.316) -
Itaituba 0.050 (0.034,0.072) -
Traira˜o 0.138 (0.092,0.203) -
Sucuriju 0.005 (0.001,0.010) 0.069 (0.030,0.220)
Bele´m 0.015 (0.009,0.023) -
Any P. falciparum Anaja´s 0.008 (0.003,0.013) 0.014 (0.001,0.040)
Jacareacanga 0.017 (0.009,0.030) 0.514 (0.042,26.272)
Goiane´sia do Para´ 0.018 (0.012,0.024) 0.047 (0.023,0.075)
Itaituba 0.004 (0.001,0.007) 0.014 (0.001,0.029)
Traira˜o 0.011 (0.006,0.017) 0.024 (0.005,0.058)
Sucuriju - -
Bele´m 0.002 (0.000,0.004) ,0.001 (0.000,0.007)
For P. vivax seropositivity data the best model assumes (i) a single seroconversion rate for every site apart from Sucuriju where a changed in seroconversion
rate seemed to have occurred 14 years ago and (ii) two seroreversion rates, one for Anaja´s, Jacareacanga, Goiane´sia do Para´, Itaituba and Traira˜o
(r50.054, 95%CI5(0.033,0.081)), and another one for Sucuriju and Bele´m (r50.018, 95%CI5(0.002,0.039)). For P. falciparum data, the best model
assumes: (i) a change in force of infection occurred 29 years ago and (ii) a common seroreversion rate for all study sites (r50.007, 95%CI5(0.001,0.029)).
Data of Sucuriju was not analysed due to a low number of seropositive individuals for any P. falciparum antigens.
doi:10.1371/journal.pone.0113357.t003
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correlation coefficient) (Figure 2B). In the case of Sucuriju where malaria
endemicity is low according to the Brazilian Ministry Health [35], the data is
better described by a model where a 92.8% drop in SCR (from 0.069 to 0.005)
Figure 2. Statistical analysis of seropositivity data. A. Age-adjusted seroprevalence for any P. vivax (blue solid lines) or P. falciparum antigens (red solid
lines) using appropriate reversible catalytic models. The observed seroprevalences for each Plasmodium species (blue- and red-filled circles) were pooled
according to the 10%-centiles of the underlying age distribution. Note that Sucuriju data for P. falciparum were excluded from the analysis due to the small number
of sero-positive individuals (two cases only). B. Correlation analysis for any P. vivax antigens using the annual parasite index versus seroconversion rate.
doi:10.1371/journal.pone.0113357.g002
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appears to have occurred 14 years before our data collection. SCR estimates for P.
vivax were not correlated with other measures of transmission intensity, such as
parasite prevalence (presumably because of the low numbers of individuals who
were found to be parasite positive). All positive individuals were infected with P.
vivax, except for one case in Goiane´sia do Para´ which was infected with P.
falciparum (Table 2). There are few entomological inoculation rate (EIR)
estimates for P. vivax to allow a robust and reliable correlation.
Likewise for age-adjusted seroprevalence curves, P. vivax antibody titers also
increase with age and then reaching a plateau (Figure 3). Variations were observed
for this plateau but these do not exceed one order of magnitude across sites. More
importantly, variation seems more easily defined by the speed by which the
plateau is reached, thus reflecting the rate of malaria exposure. Overall, the sites
seem to be divided into two main clusters in line with those defined earlier based
on API (Figure S1A). The first one is formed by Anaja´s, Jacareacanga, Goiane´sia
do Para´ and Traira˜o, where the P. vivax antibody level plateau is achieved at a
younger age (,20 years old) due to higher malaria transmission and exposure. In
the second cluster - Itaituba, Sucuriju, and Bele´m - the peak antibody level is
reached at an older age (,30 years old), reflecting a low malaria exposure. Similar
clustering can be observed using age-adjusted seroprevalence curves (Figure S1B).
Comparison of P. vivax and P. falciparum serological data
All P. falciparum seroconversion curves were best described by a model assuming
a change in disease transmission occurred ,29 years before our sampling was
conducted (Table 3). Historical SCR (older than 29 years ago) varied between
,0.001 (Bele´m) to 0.514 (Jacareacanga) while current SCR range from 0.002
(Bele´m) to 0.018 (Goiane´sia do Para´). No model was fitted to Sucuriju data
because of its low seroprevalence (two seropositive individuals only, Table 2).
Using SCR-EIR relationship established for P. falciparum in Africa, these values
represent an overall range of EIR of .0.1 infectious bites per person per year (ib/
p/yr) to 1 ib/p/yr except in Jacareacanga where the historical SCR (l1) suggests an
EIR of .20ib/p/yr.
In line with the seroprevalence data, the age-adjusted antibody profiles are
lower in the P. falciparum than in P. vivax antibody data (Figure 3). These profiles
show little variation at younger ages but a wide range of plateaus older ages
(Figure S1B). In the case of Jacareacanga, we could detect a change point in the
age-adjusted antibody titer curve around 26 years old similar to that of the
corresponding seroprevalence curve.
Discussion
This study reports data on antibodies responses to AMA-1 and MSP119 antigens
from P. vivax and P. falciparum in 1,330 individuals living in different malaria
transmission areas in the Para´ state, Brazil. Specific IgG antibody responses, either
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as titer or seroprevalence, are in good agreement with government-derived API
estimates. For P. vivax, the minimum and maximum SCRs were obtained in
Bele´m and Goiane´sia do Para´ with the lowest and the highest number of reported
Figure 3. Statistical analysis of antibody titers data. Age-adjusted log10-transformed antibody titer profiles for any P. vivax (blue solid lines) or P.
falciparum antigens (red solid lines) using appropriate Michaelis-Menten models. Blue- and red-filled circles represent the observed mean antibody titer after
pooling the data according to the 10%-centiles of the underlying age distribution. The antibody levels refer to the maximum among these reacting to AMA1
and the MSP1 antigens.
doi:10.1371/journal.pone.0113357.g003
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malaria cases, respectively. For each municipality, age-adjusted seroprevalence
curves for P. vivax antigens were higher than the ones for P. falciparum antigens,
reflecting that the predominance of infections of that species in the different study
sites. In agreement with this observation, antibody titers to P. vivax antigens tend
to reach their corresponding plateau sooner than its P. falciparum counterparts.
These data support previous work in areas where these species are co-endemic
[41, 42], showing that SCR provides a reliable tool for assessing malaria
endemicity for both species.
For the serological analysis of P. vivax reponses, age-adjusted seroprevalence
curves are best fit by simple catalytic models that assumes a stable SCR
throughout time but different estimates for the sites. These differences in SCR
estimates are likely to reflect the different ecological factors that affect malaria
exposure and the acquisition of immunity to malaria in the area. For example,
gold mining is the predominant activity in the riverine Jacareacanga. It was
previously shown that mining populations exhibit acquisition of immunity to
malaria [43]. Mining can also contribute to an increase in number of mosquito
breeding sites due to extensive borrow pits dug along mining sites, mimicking the
riverine floodwater impoundments [9]. The deforestation occurred in Goiane´sia
do Para´ might have been an important factor to the increased malaria risk in the
municipality, as observed elsewhere [17]. The coastal city of Bele´m, as the state
capital, is instead more likely to be affected by imported malaria cases due to
migration from the surrounding areas. An outlying site is Sucuriju in the Amapa´
state, where a model assuming distinct disease exposures between younger (,15
years olds) and older individuals (§15 years old) provides a better fit to the data.
Since this site has had no recorded malaria cases in recent years, possible
explanation is a past migratory wave to Sucuriju from other parts of Amapa´ or
from another surrounding state with ongoing malaria transmission. Migration is
likely to be age and season specific as reviewed elsewhere [9, 44] but the exact
nature needs further investigation.
For P. falciparum, data suggests a change in transmission occurred ,29 years
before our data collection. This estimate for the time of change in transmission is
in line with the extensive wave of emigrants from different parts of Brazil to sites
surrounding mining activities occurred in 1980s [9]. As a reaction of migration to
mining and farming sites, the Brazilian health authorities initiated several malaria
control programs. One of these programs was the SUCAM (Superintendencia de
Campanhas de Sau´de Pu´blica) which, between 1980s and 1990s, used DDT
spraying inside dwellings and actively sought and treated of cases using different
anti-malarial drugs [9]. Whilst not wholly successful, the implementation of the
program probably had a non-negligible impact on the Amazonian circulating
parasite population as shown in a recent retrospective study that suggests the
occurrence of bottlenecks on the P. falciparum parasite population of Itaituba
between the 1980s and 1990s [45]. The results further support the potential of this
serological approach to describe malaria transmission dynamics in low
transmission settings. This has been used for P. falciparum before and recently
estimated seroconversion rate has been validated with longitudinal data [46].
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However, data on P. vivax are more limited and this is the first time that
seroconversion rates have been generated for malaria-exposed populations in the
Amazon region.
There are several potential limitations of this study. The most obvious one
concerns the choice and the number of antigens used to evaluate antibody
responses. We only used antibodies to two recombinant antigens of each
Plasmodium species and, therefore, assuming some level of differential immune
responsiveness at the individual level, the data might be an under estimate of
exposure to infection occurring in the different study sites. Antibodies to other P.
vivax and P. falciparum antigens are available but their role in explaining the
natural variation in malaria immunogenicity is still not fully understood. Newer
studies have gone some way to identifying antigens or combinations of antigens
that may be more robust for this purpose [47, 48].
Other limitations are related to the timing, type and intensity of the sampling
approach. In this study data collection was performed over a 5 year period for the
different sites. Whilst the different transmission estimates can be compared and
contrasted, temporal comparison between sites reflecting changes in malaria
transmission over time or with age is more complicated. However, the profile
likelihood approach to estimate changes in transmission identifies a range of
years/age over which transmission has changed. In this case, the estimated
standard deviations were low and, therefore, broad estimate of 29 years for a
change in P.falciparum is credible. Perhaps, of more concern for the estimates is
the relatively low number of individuals sampled in each site. Besides affecting
estimation precision, the small sample size limits the likelihood of identifying
statistical significant changes in disease transmission over time from reverse
catalytic models. The current sample size has allowed estimates change in
transmission for P.falciparum that is broadly consistent across sites with plausible
biological explanations, however this may not be the case for P.vivax. Further, and
ideally larger, surveys are required to examine if changes in transmission have
occurred for P.vivax and, if not, one may ask if this is genuinely more stable
transmission perhaps as an immunological consequence of hypnozoite infection.
Future surveys will almost certainly require larger sample sizes to demonstrate
statistically significant changes in transmission when compared to current surveys
(Sepu´lveda et al. in preparation). Our surveys were also based on a convenience
sampling approach rather than structured community based sample. This could
have led to bias in those captured by the survey due to proximity of sampling
location and/or health seeking behaviour when the survey was conducted at health
facilities. We have previously conducted surveys for serological analysis using
communal meeting points [19] and also used health facility attendees [34, 49]
both approaches providing credible data. In this study for pragmatic reasons,
different sampling locations were used at the different sites following
recommendations from local contacts. There appears to be no systematic effect of
the sampling location on serological data, though we cannot rule this out
completely. A standardized approach, such as school surveys [50], would be much
more attractive but these are not always operationally or logistically possible.
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In summary, we have used serological data from anti-malaria antibody
responses to can describe areas of different malaria endemicity in Para´ state,
Brazil. We have demonstrated that seroprevalence data shows good correlation
with government-derived API and is able to detect changes in malaria
transmission in the study sites.
Supporting Information
Figure S1. Theoretical predictions for the relationship between age, mean
antibody titers, and seroprevalance. A. Expected relationships between age and
antibody titers for any P. vivax antigens using a Michaelis-Menten modelling
approach. B. Expected relationships between age and seroprevalence for any P.
vivax antigens using appropriate reversible catalytic models (see Table 3 for the
corresponding parameter estimates).
doi:10.1371/journal.pone.0113357.s001 (TIFF)
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